Cyclacel Pharmaceuticals Inc (CYCC)

Feb 24, 2025

Spiro Rombotis, CEO of Cyclacel Pharmaceuticals, on Innovative Targeted Therapies for Advanced - DocWire News

Feb 24, 2025

Feb 24, 2025

Cyclacel Pharmaceuticals amends agreement with CEO By Investing.com - Investing.com Australia

Feb 24, 2025

Feb 24, 2025

Cyclacel Pharmaceuticals amends agreement with CEO - Investing.com

Feb 24, 2025

Feb 24, 2025

(CYCCP) Trading Report - Stock Traders Daily

Feb 24, 2025

Feb 23, 2025

Head-To-Head Review: Cyclacel Pharmaceuticals (NASDAQ:CYCC) vs. Silence Therapeutics (NASDAQ:SLN) - Defense World

Feb 23, 2025

Feb 19, 2025

StockNews.com Initiates Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Feb 19, 2025

Feb 17, 2025

Cyclacel Pharmaceuticals, Inc. announced that it expects to receive $25 million in funding from Helena Special Opportunities LLC - Marketscreener.com

Feb 17, 2025

Feb 16, 2025

Cyclacel stock plunges to 52-week low of $0.31 amid market challenges - MSN

Feb 16, 2025

Feb 16, 2025

Cyclacel Pharmaceuticals streamlines operations, plans asset purchase - MSN

Feb 16, 2025

Feb 12, 2025

Cyclacel Pharmaceuticals adjusts shareholder rights, amends stock - Investing.com

Feb 12, 2025

Feb 11, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated at StockNews.com - Defense World

Feb 11, 2025

Feb 07, 2025

Cyclacel Pharmaceuticals, Inc. announced that it expects to receive $8 million in funding -February 03, 2025 - Marketscreener.com

Feb 07, 2025

Feb 05, 2025

Cyclacel Pharmaceuticals streamlines operations, plans asset purchase By Investing.com - Investing.com South Africa

Feb 05, 2025

Feb 05, 2025

Cyclacel Pharmaceuticals Announces Creditors Voluntary Liquidation Of UK Subsidiary - Marketscreener.com

Feb 05, 2025

Feb 01, 2025

How To Trade (CYCCP) - Stock Traders Daily

Feb 01, 2025

Jan 26, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 26, 2025

Jan 22, 2025

(CYCCP) On The My Stocks Page - Stock Traders Daily

Jan 22, 2025

Jan 17, 2025

All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy - MSN

Jan 17, 2025

Jan 13, 2025

Cyclacel Pharmaceuticals Corrects Inadvertent Error in Securities Purchase Agreement - Defense World

Jan 13, 2025

Jan 11, 2025

How the (CYCCP) price action is used to our Advantage - Stock Traders Daily

Jan 11, 2025

Jan 10, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.com - Defense World

Jan 10, 2025

Jan 07, 2025

Cyclacel Pharmaceuticals Announces Agreement for $3.1 Million Investment by David Lazar as Interim CEO - Defense World

Jan 07, 2025

Jan 06, 2025

Cyclacel Pharmaceuticals Restructures Leadership and Financial Strategy - TipRanks

Jan 06, 2025

Jan 03, 2025

Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar - citybiz

Jan 03, 2025

Jan 03, 2025

Stock market news: Nauticus Robotics gained 93.71% while N2OFF rose by 128.03% during mid day trading - Business Upturn

Jan 03, 2025

Jan 03, 2025

Cyclacel Pharmaceuticals, Inc. Announces Chief Executive Officer Changes - Marketscreener.com

Jan 03, 2025

Jan 03, 2025

Why Cyclacel Pharmaceuticals (CYCC) Stock Is Skyrocketing - Benzinga

Jan 03, 2025

Jan 03, 2025

Cyclacel Pharmaceuticals, Inc. Announces Board Changes - Marketscreener.com

Jan 03, 2025

Jan 03, 2025

Dow Jumps Over 100 Points; ISM Manufacturing PMI Increases In December - Benzinga

Jan 03, 2025

Jan 03, 2025

David Lazar acquires Cyclacel Pharmaceuticals preferred stock, becomes interim CEO; stock jumps - Seeking Alpha

Jan 03, 2025

Jan 03, 2025

Cyclacel Pharmaceuticals Secures $3.1M Investment, Names David Lazar as Interim CEO Amid Restructuring - StockTitan

Jan 03, 2025

Dec 30, 2024

Royal Bank of Canada (RY-T) QuotePress Release - The Globe and Mail

Dec 30, 2024

Dec 27, 2024

Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail

Dec 27, 2024

Dec 21, 2024

Trend Tracker for (CYCCP) - Stock Traders Daily

Dec 21, 2024

Dec 20, 2024

Cyclacel stock plunges to 52-week low, hits $0.32 - Investing.com India

Dec 20, 2024

Dec 17, 2024

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by StockNews.com - Defense World

Dec 17, 2024

Dec 17, 2024

Stock Watch: A Biotech Holiday Horror Story - Citeline News & Insights

Dec 17, 2024

Dec 16, 2024

Cyclacel Pharmaceuticals Faces Potential Delisting from Nasdaq Stock Market Due to Minimum Bid Price Noncompliance - Defense World

Dec 16, 2024

Dec 11, 2024

Trading (CYCCP) With Integrated Risk Controls - Stock Traders Daily

Dec 11, 2024

Dec 06, 2024

Cash-strapped Cyclacel cuts costs as it searches for financial lifeline - Fierce Biotech

Dec 06, 2024

Dec 05, 2024

Cyclacel Pharmaceuticals Exploring Alternatives, Cuts Costs to Preserve Cash - MarketWatch

Dec 05, 2024

Dec 05, 2024

Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs - The Manila Times

Dec 05, 2024